Study name | Developing and applying appropriate eligibility criteria | Measurement of exposure | Measurement of outcome | Controlling for confounding | Completeness of data |
---|---|---|---|---|---|
• Hollams [13] | • Uncertain risk | • High risk | • Low risk | • High risk | • High Risk |
• Although the risk of bias is low for the original cohort, no further details were provided about selection criteria or process for participants in this current study | • “Vit D levels was measured in thawed serum cryobanked at age 6 years” (number of years since blood draw not mentioned) | • Low for lung function and BHR | • Did not match or adjust for maternal atopy, maternal asthma, maternal age, education or household smoking | • Outcome data were missing for 30% of the enrolled cohort | |
• The used enzyme immunoassay kit “method appeared to overestimate the vitamin D levels at age 6 years” | |||||
• Measuring Vitamin D levels at one point only may not be a reliable measure of integrated 25(OH) D levels over time | |||||
Van Oeffelen [12] | • High risk | • High risk | • Low risk | • Low risk | • Uncertain Risk |
• Out of the larger cohort, a small “selected” sample included in this study, with no further details about selection provided | • Serum samples were defrosted to measure concentrations of Vitamin D (number of years since blood draw not mentioned) | for asthma (ISAAC score) Low risk for BHR | • Confounders were added to all models (gender, maternal atopy, paternal atopy, smoking by anyone in the house, and serum magnesium) | • Outcome data were missing for 12% of the enrolled cohort | |
• Measured using a competitive enzyme immunoassay in microtiter plates | |||||
• Measuring Vitamin D levels at one point only may not be a reliable measure of integrated 25(OH) D levels over time | • Also considered playing outside and overweight as potential confounders | ||||
Tolppanen [22] | • Uncertain risk | • High risk | • Uncertain risk for asthma, using spirometry & bronchidilatory responsiveness with non-validated questionnaires to diagnose asthma | • Low risk | • High risk |
• Except for the loss of follow up, the cohort was from a single community and followed specific eligibility criteria | • The exposures are standardized for age and sex and 25-hydroxyvitamin D3 is adjusted for season and ethnicity | • Model 1 unadjusted | • Of 5765 participants in the assessment of the wheezing and asthma outcome 3323 where included (42% missing data) | ||
• Measured using high pressure liquid chromatography tandem mass spectrometer in the multiple reaction mode (number of years since blood draw not mentioned) | • High risk for wheezing | • Models 2 and 3 adjusted for respectively 8 and 9 potential confounders | |||
• Recall bias | • And of 4488 participants in the spirometric assessment 2259 where included (50% missing data). | ||||
• Measuring Vitamin D levels at one point only may not be a reliable measure of integrated 25(OH) D levels over time | • Proportion of incident wheezing, and asthma was higher among children excluded owing to missing data |